Danish pharmaceutical company Novo Nordisk today launched its blockbuster type 2 diabetes treatment injection Ozempic in India.

The Ozempic will be available as 0.25 mg, 0.5 mg and 1 mg in a pen device. Each pen will have four weekly doses priced at Rs 8,800 for 0.25 mg, Rs 10,170 for 0.5 mg and Rs 11,175 for 1 mg.

Ozempic, which is indicated as an adjunct to diet and exercise for adults living with uncontrolled type 2 diabetes mellitus and globally known for its weight-loss benefits, has come to India at a crucial time. According to the World Health Organisation 2023-24 estimates, India has 101 million people (roughly 11.4% of the total population) living with diabetes, making it the second largest diabetes-affected population in the world after China.

Novo Nordisk India managing direc

See Full Page